no one here is trying to do that. I think what the issue here is just better information coming out of Generex about the uplisting and what happens now. It should not be the shareholders responsibility to find out what the 2.00 drop does or does not do. Generex should be supplying that information to the shareholders, since they are the one who put out the information in the first place.